Ciechanowicz Piotr, Dopytalska Klaudia, Szczerba Michał, Szymańska Elżbieta, Walecka Irena
Dermatology Department, Centre of Postgraduate Medical Education/Central Clinical Hospital MSWiA, Warsaw, Poland.
Faculty of Medicine, University of Technology, Katowice, Poland.
Postepy Dermatol Alergol. 2022 Jun;39(3):491-508. doi: 10.5114/ada.2020.99294. Epub 2020 Sep 25.
An increasing number of publications describing dermatoses associated with Coronavirus disease 2019 (COVID-19) have shown differences in the morphology and incidence of dermatoses in children compared to the general population.
Among 22 selected full-text articles, dermatoses associated with COVID-19 have been described in 196 children (average age: 12.57 years). Dermatoses were the only symptom in most patients ( = 134; 68.4%). RT-PCR tests of nasopharyngeal swabs confirmed SARS-CoV-2 infection in only 18 cases ( = 18/69; 26.1%).
Dermatoses described include chilblain-like lesions ( = 173; 88.3%), maculopapular rash ( = 16; 8.2%), erythema multiforme-like lesions ( = 12; 6.1%), varicella-like exanthema ( = 1; 0.5%), and urticaria ( = 1; 0.5%).
This publication aims to summarise existing data on dermatoses and to draw attention to how identification of dermatological symptoms in paediatric patients can provide a quick and reliable indicator of COVID-19.
越来越多描述与2019冠状病毒病(COVID-19)相关皮肤病的出版物表明,与普通人群相比,儿童皮肤病的形态和发病率存在差异。
在22篇选定的全文文章中,描述了196名儿童(平均年龄:12.57岁)与COVID-19相关的皮肤病。皮肤病是大多数患者(=134;68.4%)的唯一症状。仅18例(=18/69;26.1%)鼻咽拭子的RT-PCR检测证实感染了严重急性呼吸综合征冠状病毒2(SARS-CoV-2)。
所描述的皮肤病包括冻疮样病变(=173;88.3%)、斑丘疹(=16;8.2%)、多形红斑样病变(=12;6.1%)、水痘样疹(=1;0.5%)和荨麻疹(=1;0.5%)。
本出版物旨在总结关于皮肤病的现有数据,并提请注意如何通过识别儿科患者的皮肤症状来提供COVID-19的快速可靠指标。